Patents by Inventor Lindsi McCoard

Lindsi McCoard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS COMPOSED OF LOW MOLECULAR WEIGHT SULFATED HYALURONAN
    Publication number: 20170095501
    Abstract: Described herein are pharmaceutical compositions composed of low molecular weight sulfated hyaluronan.
    Type: Application
    Filed: December 16, 2016
    Publication date: April 6, 2017
    Applicant: UNIVERSITY OF UTAH RESEARCH FOUNDATION
    Inventors: Glenn D. Prestwich, Siam Oottamasathien, Wanjian Jia, Lindsi McCoard, Won Yong Lee
  • Methods for treating or preventing urological inflammation
    Patent number: 9522162
    Abstract: Described herein are methods for treating or preventing urological inflammation in a subject comprising administering to the subject an effective amount of a compound comprising a. a modified hyaluronan or a pharmaceutically acceptable salt or ester thereof, wherein said hyaluronan or its pharmaceutically acceptable salt or ester comprises at least one sulfate group and at least one primary C-6 hydroxyl position of an N-acetyl-glucosamine residue comprising an alkyl group or fluoroalkyl group; b. a partially or fully sulfated hyaluronan or the pharmaceutically acceptable salt or ester thereof, or a combination thereof.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: December 20, 2016
    Assignee: University of Utah Research Foundation
    Inventors: Glenn D. Prestwich, Siam Oottamasathien, VIII, Wanjian Jia, Lindsi McCoard, Won Yong Lee
  • METHODS FOR TREATING OR PREVENTING UROLOGICAL INFLAMMATION
    Publication number: 20140343011
    Abstract: Described herein are methods for treating or preventing urological inflammation in a subject comprising administering to the subject an effective amount of a compound comprising a. a modified hyaluronan or a pharmaceutically acceptable salt or ester thereof, wherein said hyaluronan or its pharmaceutically acceptable salt or ester comprises at least one sulfate group and at least one primary C-6 hydroxyl position of an N-acetyl-glucosamine residue comprising an alkyl group or fluoroalkyl group; b. a partially or fully sulfated hyaluronan or the pharmaceutically acceptable salt or ester thereof, or a combination thereof.
    Type: Application
    Filed: March 23, 2012
    Publication date: November 20, 2014
    Applicant: UNIVERSITY OF UTAH RESEARCH FOUNDATION
    Inventors: Glenn D. Prestwich, Siam Oottamasathien, VIII, Wanjian Jia, Lindsi McCoard, Won Yong Lee
  • Methods for treating interstitial cystitis
    Patent number: 8343942
    Abstract: Described herein are methods for treating interstitial cystitis in a subject comprising administering to the subject an effective amount of a compound which is a modified hyaluronan or a pharmaceutically acceptable salt or ester thereof, wherein said hyaluronan or its pharmaceutically acceptable salt or ester comprises at least one sulfate group and the primary C-6 hydroxyl proton of at least one N-acetyl-glucosamine residue is substituted with an unsubstituted alkyl group or fluoroalkyl group.
    Type: Grant
    Filed: March 23, 2011
    Date of Patent: January 1, 2013
    Assignee: University of Utah Research Foundation
    Inventors: Siam Oottamasathien, Wanjian Jia, Glenn D. Prestwich, Lindsi McCoard
  • METHODS FOR TREATING OR PREVENTING UROLOGICAL INFLAMMATION
    Publication number: 20120021968
    Abstract: Described herein are methods for treating or preventing urological inflammation in a subject comprising administering to the subject an effective amount of a compound comprising a. a modified hyaluronan or a pharmaceutically acceptable salt or ester thereof, wherein said hyaluronan or its pharmaceutically acceptable salt or ester comprises at least one sulfate group and at least one primary C-6 hydroxyl position of an N-acetyl-glucosamine residue comprising an alkyl group or fluoroalkyl group; b. a partially or fully sulfated hyaluronan or the pharmaceutically acceptable salt or ester thereof, or a combination thereof.
    Type: Application
    Filed: March 23, 2011
    Publication date: January 26, 2012
    Applicant: UNIVERSITY OF UTAH RESEARCH FOUNDATION
    Inventors: Siam Oottamasathien, Wanjian Jia, Glenn D. Prestwich, Lindsi McCoard